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Material and Methods
Bacterial strains and culture conditions HK100 and BL21(DE3) E. coli strains were routinely grown in LB broth at 37°C and used for cloning and expression experiments, respectively. Staphylococcus Newman strain was grown in Tryptic soy medium under aerobic conditions and CFUs were estimated by plating bacteria on Tryptic soy agar plates. Stock preparations of E. coli strains in LB +15% glycerol and S. aureus in TSB+15% glycerol were stored at -80°C. Each bacterial manipulation was started using an overnight culture from a frozen stock. When required ampicillin was added to final concentration of 100 µg/ml.
Plasmids and strains construction and OMVs preparation
BL21(DE3)ΔompA strain was generated as previously described (1) . BL21 (DE3)ΔompAΔmsbBΔpagP strain was generated using the CRISPR/Cas genome editing strategy (2) . Briefly, the BL21(DE3)ΔompA strain was transformed with pCasRed plasmid encoding the Cas9 endonuclease, the tracrRNA and the λRed cassette. Subsequently, BL21(DE3)ΔompA (pCasRed) was co-transformed with a mutagenic double-stranded donor DNA (ds-dDNA, Table S2 ) and the pCRISPR-SacB-gDNA plasmid, which carries a synthetic DNA fragment (Table S2 ) coding for a gene specific RNA guide necessary to direct the Cas9 to the target site. The ds-donor DNA was designed to cause a whole gene deletion. Positive mutants were identified by colony PCR with gene specific primers (Table   S2 ).
To express the five S. aureus antigens HlaH35L, LukE, FhuD2, Csa1A and SpAKKAA the coding sequences were chemically synthetized (Genart-Invitrogen) and PCR amplified using the primers reported in Table S2 . The PCR products were inserted into plasmids pET-OmpA or pET-Lpp plasmid, two pET21 derivatives carrying the sequence encoding the leader peptide for secretion of E. coli OmpA or Lpp, respectively, using the polymerase incomplete primer extension (PIPE) cloning method (3) . Plasmids were linearized using the primers couples: omprev/nohisflag and Lpp-R-plasmid/nohisflag (Table S2 ). The correctness of the cloning was verified by sequence analysis. pET plasmid derivatives containing the genes of interest were transformed into BL21(DE3)ΔompA and BL21 (DE3)ΔompAΔmsbBΔpagP strains. Recombinant clones were grown in 200 ml LB medium (starting OD600=0.05) and, when the cultures had reached an OD600 value of 0.5, recombinant protein expression was induced by addition of 0.1 mM IPTG.
Purification of recombinant S. aureus antigens and limited proteolysis of LukE,
FhuD2 and Csa1A
Recombinant S. aureus antigens were purified using the TEV protease purification strategy (4). Briefly, the synthetic genes coding for SpaKKAA, HlaH35L, LukE, FhuD2 and Csa1A were fused at their 5' to the sequence coding for a His6-tag and the TEV cleavage site. The constructs were cloned in a pET15 plasmid downstream of a T7 inducible promoter and expressed in E. coli BL21(DE3) strain. Bacterial biomass, 5 g wet weight, was resuspended in 50 ml buffer A (50 mM NaH2PO4, 300 mM NaCl, pH 8.0) in the presence of a protease inhibitor (0.2 mM PMSF), sonicated thoroughly at 4°C and the total cell lysate was finally centrifuged (15.000 x g, 30 min, 4°C). The supernatant was filtered (0.22 µm) and applied to Ni-affinity chromatography (IMAC) using an ÄKTA purifier System (GE) 
Western blot and flow cytometry analysis
Western blot analysis was performed as previously reported (1) . The polyclonal antibodies against each antigen were obtained from Genscript by immunizing rabbits with specific England Biolabs and Roche, respectively. Flow cytometry analysis on E.coli strain expressing lipidated FhuD2 was performed as previously described (5) . Primary antibody against FhuD2 was obtained from Genscript as described above.
Triton X-114 protein separation from OMVs
OMVs (100 g of proteins) were diluted in PBS, ice cold TritonX-114 was added to 1%
final concentration and the OMV-containing solution was incubated at 4°C for 1 h under shaking. The solution was then heated at 37°C for 10 minutes and the aqueous phase was separated from the detergent by centrifugation at 13,000 g for 10 min. Proteins in both phases were then precipitated by standard chloroform/methanol procedure, separated by SDS-PAGE electrophoresis and the protein of interest visualized by Western blot.
LPS purification and Mass spectrometry analysis
LPS extraction
Bacterial cells, harvested from 1 L culture, were washed twice with ethanol, acetone and petroleum ether, then dried at room temperature. 5 ml of 90% phenol solution was added to the dried cells, the suspension was heated at 70°C and vigorously stirred for 30 minutes.
Samples were cooled on ice and centrifuged for 20 minutes at 6,000 rpm. The water phase was collected and dialyzed for two days against water. DNase and RNase (10mg of each) digestion was performed incubating for 3 hours at 37°C, followed by digestion with Proteinase K. After overnight dialysis against water, the LPS was lyophilized in a rotatory evaporator (Büchi Labortechnik AG, Flawil, Switzerland). Dried LPS was weighted and dissolved in water in a 1-2% solution.
LPS acidic hydrolysis
The protocol for LPS hydrolysis was slightly modified from that of El Hamidi et al. (6) .
Briefly, LPS was cleaved by acidic hydrolysis in 2% acetic acid at 100°C for 2 h under stirring and reflux. The mixture was centrifuged at 3,000 rpm for 30 min at RT, the recovered pellet was re-suspended in 1 ml of chloroform: methanol: water 3:2:0.25 (v/v) and the solution was centrifuged at 3,000 rpm for 15 min. The organic phase containing lipid A was collected and the extraction was repeated on the aqueous phase. The pooled organic phases were dried in a rotatory evaporator and re-suspended in 500 µl of chloroform: methanol 4:1 (v:v).
Reverse Phase Liquid Chromatography-ElectroSpray Ionization-Mass Spectrometry (RPLC-ESI-MS)
The daily for a 7-day period. Animals health was evaluated using a 1 to 4 pain scale. A value of 4 was given to mice with: loss of weight >15%, very rough hair coat, impaired mobility.
A score of 3 was given to mice with loss of weight of about 15% and rough hair coat, while scores of 2 and 1 were given to mice with a loss of weight between 6% and 14% or 0% and 5%, respectively. All procedures were approved by the National Health Institution and Ethical Committee and for human reasons animals were sacrificed at symptoms of sickness as recommended by 3Rs rules (''Refinement, Reduction, Replacement'' policy towards the use of animals for scientific procedures_ 99/167/EC, Council Decision of 25/1/99).
Experiments using the renal abscess and skin infection model were performed as previously described (7) . For the renal model mice were challenged i.v. 10 days after the third immunization with 1 x 10 7 colony forming units (CFUs) of S. aureus Newman strain, while in the skin infection model mice were challenged s.c. 14 days after the second immunization with 5 x 10 7 CFUs of S. aureus Newman strain.
ELISA assays on mice sera collected after immunizations were performed as previously described (1).
Hla neutralization assay was performed as previously described (7) with some minor modifications. Briefly, serial twofold dilutions of antisera against "Empty"-OMV, rHlaH35L
and HlaH35L-OMVs were incubated with 20 ng rHla (Abcam) for 20 min at 37°C. Then, erythrocytes derived from de-fibrinated rabbit blood were added, and incubation was prolonged for a further 15 min at 37 °C. Incubation with water was used as a positive control (maximal hemolysis). Plates were then centrifuged for 5 min at 1,000 × g, and the supernatant was analyzed spectrophotometrically by an absorbance microplate reader at 540 nm.
LPS analysis by Mass Spectrometry
The LPS was purified from the four strains and the Lipid A was analysed by Reverse Phase Liquid Chromatography-ElectroSpray Ionization-Mass Spectrometry (RPLC-ESI-MS).
The spectra obtained for the four preparations are shown in Figure 5 . The total ion current (TIC) of Lipid A from BL21(DE3)ΔompA strain showed a predominant peak (hexa-Ac, First, the tetracylated monophosphoryl species (tetra-Ac) was more abundant compared to the Lipid A from the same strain not expressing lipidated FhuD2. Second, both penta-and tetra-acylated phosphorylethanolamine analogues (penta-Ac-PE and tetra-Ac-PE) were completely missing in the Lipid A preparation of this strain ( Figure 5 and Figure 1S ).
Considering that the tetra-acylated monophoryl lipid A is known to have a poor TLR4 agonistic activity and that phosphorylethanolamine modification slightly enhances the TLR4 agonistic activity of Lipid A, these data offer an explanation of the reduced TLR4 stimulation of the OMVsmsbBpagP decorated with the lipidated antigens (see also Discussion). 
